Novel Oral Anticoagulant Use Among Patients with Atrial Fibrillation Hospitalized with Ischemic Stroke or Transient Ischemic Attack

BACKGROUND: Novel oral anticoagulants (NOACs) have been shown to be at least as good as warfarin for preventing stroke or transient ischemic attack (TIA) in patients with atrial fibrillation (AF), yet diffusion of these therapies and patterns of use among AF patients with ischemic stroke and TIA hav...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circ Cardiovasc Qual Outcomes
Hlavní autoři: Patel, Priyesh A., Zhao, Xin, Fonarow, Gregg C., Lytle, Barbara L., Smith, Eric E., Xian, Ying, Bhatt, Deepak L., Peterson, Eric D., Schwamm, Lee H., Hernandez, Adrian F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4512906/
https://ncbi.nlm.nih.gov/pubmed/26058721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.114.000907
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky